$ACOL NEWS OUT
Acology Gains as Canada Prepares for Legalization
CORONA, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Executives of Acology Inc. (OTC:ACOL), in response to investor inquiries about the company's multinational expansion, have expressed confidence that the anticipated legalization of recreational cannabis in Canada will produce growth and strong, sustained retail and wholesale business.
With the Canadian National Government, led by strong, pro-cannabist Prime Minister Justin Trudeau, ready to ask for legalization in the next few weeks and the high likelihood of the referendum passing, companies that have anticipated legalization are in a good position to benefit from the new law.
The investment in Canadian expansion, where Acology has had a business operations since 2013, began in the last quarter of calendar 2017 and has already begun to produce steady increases in sales in the first quarter of 2017. Recent high-level meetings with other Canadian cannabis firms and potential distributors have continued amid the growing confidence in the expanding market.
The Canadian market potential has been estimated at $10B in the first full year. Distribution points for both medical and recreational cannabis, serving what will be a rapidly-expanding consumer market, have been the focus of much of Acology's expansion effort. There is growing confidence that these expansion points will provide the market increase that they have been preparing for.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company's websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc.
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.
Acology Gains as Canada Prepares for Legalization
CORONA, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Executives of Acology Inc. (OTC:ACOL), in response to investor inquiries about the company's multinational expansion, have expressed confidence that the anticipated legalization of recreational cannabis in Canada will produce growth and strong, sustained retail and wholesale business.
With the Canadian National Government, led by strong, pro-cannabist Prime Minister Justin Trudeau, ready to ask for legalization in the next few weeks and the high likelihood of the referendum passing, companies that have anticipated legalization are in a good position to benefit from the new law.
The investment in Canadian expansion, where Acology has had a business operations since 2013, began in the last quarter of calendar 2017 and has already begun to produce steady increases in sales in the first quarter of 2017. Recent high-level meetings with other Canadian cannabis firms and potential distributors have continued amid the growing confidence in the expanding market.
The Canadian market potential has been estimated at $10B in the first full year. Distribution points for both medical and recreational cannabis, serving what will be a rapidly-expanding consumer market, have been the focus of much of Acology's expansion effort. There is growing confidence that these expansion points will provide the market increase that they have been preparing for.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company's websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc.
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.
Advanced Container Technologies Inc. (ACTX) Stock Research Links
Follow me on Twitter @KyleDeel for more picks like this one!
